Alkermes Plc

Common Name
Alkermes
Country
Ireland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,800
Ticker
ALKS
Exchange
NASDAQ/NGS
Description
Alkermes plc is a prominent biopharmaceutical company focusing on the development and commercialization of innovative medicines aimed at addressing unmet medical needs in major therapeutic areas such ...

Alkermes's GHG Emissions Data Preview

In 2023, Alkermes completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Alkermes has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Alkermes’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alkermes’s data sources below and access millions more through our Disclosure Search.

a. Alkermes's Corporate Responsibility Report (CRR) 2024
a. Alkermes's Corporate Responsibility Report (CRR) 2024

Insights into Alkermes's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Alkermes amounted to 46,320.264 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Alkermes decreased by 5.85%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Alkermes's Scope 1 Emissions Over Time

20182019202020212022202304.5 k9 k13.5 k18 ktCO2e+40%-9%+11%+13%-9%
  • Total Scope 1
  • Year-over-Year Change

What are Alkermes's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Alkermes were 14,762.887 metric tons of CO₂ equivalent (tCO₂e). a

Has Alkermes reduced its Scope 1 emissions over time?

Since 2018, Alkermes's Scope 1 emissions have increased by 44.35%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), Alkermes's Scope 1 emissions decreased by 9.14%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Alkermes's Scope 2 emissions?

In 2023, Alkermes reported Scope 2 greenhouse gas (GHG) emissions of 31,557.377 tCO₂e without specifying the calculation method. a

Has Alkermes reduced its Scope 2 emissions over time?

Since 2018, Alkermes's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 13.24%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2022), Alkermes's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Alkermes 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Alkermes use for Scope 2 reporting?

In 2023, Alkermes reported its Scope 2 emissions using an unspecified methodology. a

Alkermes's Scope 2 Emissions Over Time

20182019202020212022202308.5 k17 k25.5 k34 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Alkermes’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Alkermes reported Scope 1 greenhouse gas (GHG) emissions of 14,762.887 tCO₂e and total revenues of USD 1,663 millions. This translates into an emissions intensity of 8.88 tCO₂e per millions USD. a

Alkermes's Scope 1 Emissions Intensity Compared to Peers

2002,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)2005001,0005,00010,000Revenues (Millions of USD)CDDSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MAurobindo PharmaYear: 2025Scope 1: 750,616 tCO2eRevenue: $M 3,672Scope 1 Intensity: 204.39 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MEisaiYear: 2024Scope 1: 45,666 tCO2eRevenue: $M 4,898Scope 1 Intensity: 9.32 tCO2e/$MShionogi & CoYear: 2023Scope 1: 40,373 tCO2eRevenue: $M 3,203Scope 1 Intensity: 12.60 tCO2e/$MHikma PharmaceuticalsYear: 2024Scope 1: 38,468 tCO2eRevenue: $M 2,307Scope 1 Intensity: 16.67 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MH LundbeckYear: 2024Scope 1: 20,409 tCO2eRevenue: $M 3,067Scope 1 Intensity: 6.66 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MGedeon RichterYear: 2024Scope 1: 45,632 tCO2eRevenue: $M 2,171Scope 1 Intensity: 21.02 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MPerrigoYear: 2023Scope 1: 68,712 tCO2eRevenue: $M 4,656Scope 1 Intensity: 14.76 tCO2e/$MSwedish Orphan BiovitrumYear: 2024Scope 1: 1,097 tCO2eRevenue: $M 2,362Scope 1 Intensity: 0.46 tCO2e/$MIpsenYear: 2024Scope 1: 9,932 tCO2eRevenue: $M 3,720Scope 1 Intensity: 2.67 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MDr Reddy's LaboratoriesYear: 2025Scope 1: 142,772 tCO2eRevenue: $M 3,810Scope 1 Intensity: 37.47 tCO2e/$MSumitomo PharmaYear: 2023Scope 1: 27,093 tCO2eRevenue: $M 4,171Scope 1 Intensity: 6.50 tCO2e/$MAlkermesYear: 2023Scope 1: 14,763 tCO2eRevenue: $M 1,663Scope 1 Intensity: 8.88 tCO2e/$M

How does Alkermes's GHG emissions intensity compare to its peers?

In 2023, Alkermes reported a Scope 1 emissions intensity of 8.88 tCO₂e per millions USD. Compared to the peer group median of 15.72 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Alkermes rank on GHG emissions intensity within its industry?

In 2023, Alkermes ranked 9 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Alkermes is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Alkermes's GHG Emissions Dataset?
Sign Up